Impax Laboratories is now part of
On May 4, 2018, Amneal Pharmaceuticals and Impax Laboratories combined under one corporate parent,
and now operate as Amneal Pharmaceuticals. Amneal Pharmaceuticals, Inc. is a publicly listed company
traded on the New York Stock Exchange (NYSE: AMRX).
For Product Questions, Comments and Returns:
Amneal, Impax and/or Gemini Laboratories Products: Report adverse events, product quality complaints
and for medical information inquiries in the United States.
Call: (877) 835-5472, option 1 or email: DrugSafety@amneal.com